UB CENTER FOR ADVANCED BIOMEDICAL AND BIOENGINEERING TECHNOLOGY
UB CAT Co-Directors
Alexander Cartwright, PhD, Vice President for Research and Economic Development, University at Buffalo
Marnie LaVigne, PhD, Associate Vice President for Economic Development, University at Buffalo
Now Accepting Project Applications!
UB CAT is now accepting 2013-2014 technology development project applications through our annual RFP. Applications are due May 3, 2013.
To learn more about the process and whether your project is eligible, contact Marnie LaVigne, PhD, at firstname.lastname@example.org or 716-881-8904.
Please click on the following links for more information:
2013-2014 Project Requirements
UB CAT project applications are selected for funding based on the following criteria:
- Within the scope of the UB CAT focus area in life sciences
- Scientific, technical, and innovative merit
- Commitment of a University at Buffalo Principal Investigator*
- New York State-based company sponsor with available matching funds**
- Demonstrated need for support of project
- Appropriateness of budget items within UB CAT guidelines
- Ability of company sponsor to successfully complete project within July 1, 2013 through June 30, 2014
- Potential economic impact for New York State***
* All projects are subject to State University of New York intellectual property policies. Principal Investigator eligibility is dependent on policy guidelines at the University at Buffalo (http://policy.business.buffalo.edu/Pages/RSH.aspx).
** UB CAT anticipated matching ratio for the 2013 – 2014 fiscal year is $1.00 CAT to $1.50 company match for small companies (< 100 employees) and $1.00 CAT to $2.50 company match for large companies (> 100 employees). A typical CAT contribution is $10,000 to $50,000.
*** Economic impact resulting from a project is defined as an increase in company sponsor revenues (federal, non-government, product-based), cost savings to company, new jobs created, jobs saved, capital expenditures by company sponsor, intellectual property development, new company start-up opportunity or company relocation / expansion in New York State.
Who Should Apply?
The UB CAT project application is open to any company representative and researcher who meet the “Project Requirements” above.
If you are a company representative with a potential project, please contact us directly to facilitate introductions with appropriate University at Buffalo Principal Investigators, if needed.
If you are a researcher with a potential project and a target New York State company, please contact us directly to facilitate any appropriate introductions within our business network.
The annual request for proposals is issued in March with an application due date of May 3, 2013 for the following fiscal year. Potential projects can also be received on a rolling basis throughout the year given availability of funds. Please click here for an application. When completed, send to Marnie LaVigne, PhD, at email@example.com.
Applications received by the UB CAT are subject to approval by the UB CAT Industrial Advisory Board. This board consists of professionals in the life sciences area who are uniquely qualified to evaluate projects and comment on appropriateness of work being conducted through the UB CAT funding vehicle. Please click here for a list of the UB CAT Industrial Advisory Board members.
Award announcements will be made directly to the applicant prior to the project’s execution. Awards issued in response to proposals submitted no later than May 3, 2013 will be announced prior to July 1, 2013 pending availability of funding and NYSTAR approval. Award announcements for applications received on a rolling basis are announced following review by the UB CAT Industrial Advisory Board.
Upon receiving project approval by the UB CAT, a company sponsor will enter into a contracting period followed by account set-up and project initiation. Principal Investigators are required to file Sponsored Project approval paperwork with the appropriate department leadership and Sponsored Programs to initiate account set-up. Reporting of economic impact is required for a minimum of five years for all company sponsors following completion of a UB CAT project.
- UB CAT cost sharing support is awarded on an annual basis. Both UB CAT and company sponsor matching funds must be expended by the close of the University fiscal year, June 30, 2014.
UB CAT cost sharing support can be used to cover expenses associated with University personnel and for purchasing of supplies, materials, testing or other contracted services and equipment related to the project.
- Overhead costs for UB CAT projects is limited to 15% of salary and fringe benefits for University personnel
- Equipment purchased by any project funds (CAT or company sponsor) is considered property of the CAT and eligible for use in future projects. Equipment purchases must follow University property policies and NYSTAR program policies.
Funds CANNOT be expended for:
- Rent, capital construction, rehabilitation, renovation, upgrading of existing space or infrastructure, telecommunications, utility costs or legal expenses.
- Basic research or research projects that do not receive matching funds support from a company.
- Costs associated with employees of the sponsor company.
- Reimbursement to sponsor company for any expenses the sponsor has already paid.
UB CAT Mission
The University at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT) is one of 15 centers across New York State supporting university-industry collaboration in research, education and technology transfer, with a strong focus on helping New York State-based businesses gain a technological edge on their competition. The UB CAT is fueling continued growth in promising technologies of tomorrow across the life sciences spectrum including biotechnology, biomedical informatics, diagnostics, medical devices, pharmaceuticals, and research and development products or services. The UB CAT fosters the creation of new life sciences companies and helps existing businesses expand through new or improved product lines by utilizing the R&D assets and expertise within the University. Projects supported by the UB CAT drive substantial economic impact for New York State annually. Hand-in-hand with funding, the UB CAT also provides R&D resources, business development assistance, workforce development programming, and other outreach and networking opportunities. The UB CAT operates within the New York State Center of Excellence in Bioinformatics & Life Sciences (CoE) under the leadership of Dr. Marnie Lavigne associate Vice President for Economic Development at UB, and Dr. Alexander Cartwright Vice President for Research and Econocmic Development at UB.
The 2011-2012 State Budget merged NYSTAR into Empire State Development and created a new Division of Science, Technology and Innovation (NYSTAR). The merger recognized the integral role of innovation to economic growth in the state. Click here to learn more.
UB CAT Contact Information
For questions or to submit a UB CAT application for funding, please contact:
Marnie LaVigne, Ph.D.
Associate Vice President for Economic Development
University at Buffalo
701 Ellicott Street
Buffalo, NY 14203
Office: 716.881.8904 Email: firstname.lastname@example.org
UB Center for Advanced Biomedical and Bioengineering Technology
NYS Center of Excellence in Bioinformatics & Life Sciences
701 Ellicott Street
Buffalo, NY 14203
Office: 716.888.4728 Email: email@example.com
Visit the website to learn more at www.isciwny.com
Follow cool careers:
To view the complete list of events and event details, please visit our Events page.
New York Biotechnology Association 22nd Annual Meeting
May 29, 2013 - May 30, 2013
UVANY Venture Forum - Connecting Innovation Economies: A Cross-Border Perspective
May 29, 2013
2nd Annual WNYSTEM Stem Cell Symposium
June 1, 2013
To receive periodic News & Events emails from the COE, please join our mailing list!
The James H. Cummings Foundation has presented a gift of $1 million to the Buffalo Niagara Medical Campus. The gift will help establish the James H. Cummings Foundation Epilepsy Monitoring Center at the John R. Oishei Children's Hospital. This gift supports a $40 million campaign for the $220 million, 12-story hospital project, and the Epilepsy Monitoring Center will replace the existing eight-bed unit housed on the 7th floor of the Women & Children's Hospital of Buffalo.
Sentient Science Corp. has moved their headquarters to the former Butler's Mansion on Delaware. The company has maintained its research and development facility in Idaho Falls. The move was made after local groups and elected officials helped Sentient Science Corp. connect with computer scientists and engineers at UB.
Visit the News Archive